Sophie Kornowski, PharmD

Chief Executive Officer

Sophie Kornowski, PharmD was appointed Chief Executive Officer and Chair of the Board of Boston Pharmaceuticals in 2022. Since 2018, Sophie has also been a partner at Gurnet Point Capital, a private investment firm focused on the healthcare sector. Throughout this time, Sophie has worked closely with the Boston Pharmaceuticals team as a member of the Board of Directors and, at the request of the Board, has been supporting Corporate Development efforts.

Prior to joining Gurnet Point Capital, she was Executive Vice-President of Roche Partnering and member of the Extended Corporate Executive Committee of F. Hoffmann-La Roche AG, one of the world's largest healthcare companies, and board member of Chugai Pharmaceuticals. In that role, working closely with R&D and Commercial teams at Roche and Genentech, she was responsible for the Partnering and the M&A strategy with Biotechs, Pharma, HealthTech and Research Institutions worldwide for Roche.  Previously, Dr. Kornowski had led the largest affiliate of F. Hoffmann-La Roche outside of the US, based in France, for many years. Earlier in her career, she held several leadership commercial roles across geographies in leading innovative pharmaceutical and diagnostic companies in France, Israel and the US. Dr. Kornowski holds an M.B.A. from the University of Chicago and a Doctorate in Pharmacy from Paris Descartes University.